Importantly, we consistently observed a more significant change in collagen IV expression levels and structure in anti-Lair1 antibody–treated LLC1 tumors (Figure 6, E and F), reproducing the findings from the GBM model in Lair1–/– mice. The gene discussed is LAIR1; the disease is glioblastoma.